ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1290

Adverse Childhood Experiences: Prevalence and Relationship to Disease and Mental Health Outcomes in Childhood-Onset Systemic Lupus Erythematosus (cSLE)

Jin Xuan Zhou1, Stephanie Fevrier2, Paris Moaf2, Lawrence Ng3, Asha Jeyanathan4, Louise Boulard2, Deborah Levy1, Linda Hiraki1, Ashley Danguecan5 and Andrea Knight5, 1The Hospital for Sick Children, Toronto, ON, Canada, 2Hospital for Sick Children, Toronto, Canada, 3The Hospital for Sick Children, Toronto, Canada, Toronto, ON, Canada, 4The Hospital for Sick Children, Toronto, Canada, 5Hospital for Sick Children, Toronto, ON, Canada

Meeting: ACR Convergence 2025

Keywords: autoimmune diseases, mental health, Outcome measures, Patient reported outcomes, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1272–1305) Pediatric Rheumatology – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Childhood-onset systemic lupus erythematosus (cSLE) is an autoimmune disease characterized by multi-organ inflammation, alongside high frequencies of mood disorders and cognitive impairment. Adverse Childhood Experiences (ACEs) quantify traumatic childhood events, which have been linked to altered immune response and increased chronic disease risk. Prior studies indicate those with ≥ 4 ACEs, including adults with SLE, face higher risk of worse health outcomes. Limited research exists on ACEs in cSLE. We aimed to describe the prevalence of ACEs among cSLE patients and investigate associations with i) disease activity, ii) patient-reported outcome measures, and iii) self-reported executive function.

Methods: This cross-sectional study analyzed prospective data from cSLE patients aged 13-19 years at the time of assessment. The Pediatric ACEs and Related Life Events Screener (PEARLS) measured 19 self-reported ACEs. Disease activity over the time since diagnosis was measured by the adjusted mean Systemic Lupus Erythematosus Disease Activity Index (SLEDAI-2K). The Patient Reported Outcomes Information System (PROMIS) Pediatric-37 Profile assessed patient-reported anxiety, depression, and fatigue. The Behavior Rating Inventory of Executive Function (BRIEF-2) Global Executive Composite score measured executive function. The frequency of ACEs types was tabulated, and patients were classified into high-risk (≥ 4 ACEs) and low-risk (≤ 3 ACEs) groups. Associations between ACEs risk group and the outcomes were examined using regression analyses with generalized linear models, adjusted for age.

Results: Of 50 cSLE patients (mean age 15.20 ± 1.86 years, 84% female), 72% reported at least 1 ACE, and 30% reported ≥ 4 ACEs (Table 1). The most common ACEs were caregiver verbal abuse, emotional neglect, and separation, as well as community violence (Figure 1). Being in the high-risk ACEs group compared to low risk, was significantly associated with worse scores for PROMIS anxiety (p< 0.001), depression (p< 0.001), and fatigue (p< 0.001), alongside poorer executive function scores (p< 0.001) (Figure 2). No significant associations were observed for disease activity (p=0.263).

Conclusion: Within our cSLE cohort, ACEs were substantially prevalent, with almost a third of patients having experienced ≥ 4 ACEs. The high risk group had significantly worse patient-reported outcomes and executive function. These results underscore the impact of ACEs on patient well-being, emphasizing the need for integrated medical and mental health care approaches. Future research should examine these associations in larger cohorts.

Supporting image 1

Supporting image 2Figure 1 illustrates the distribution of nineteen self-reported adverse childhood experiences (ACEs) types within our cSLE cohort (n=50). Among the total ACEs (n=135) self-reported on the patient PEARLS questionnaire, the most commonly reported ACEs were caregiver verbal abuse (n=18), community violence (n=14), emotional neglect (n=14), and caregiver separation/divorce (n=14).

Supporting image 3Figure 2 contains four sets of boxplots depicting differences in mean outcome scores between the high-risk and low-risk ACEs groups. Associations show beta coefficients, confidence intervals, and p-values from regression analyses. Regression analyses showed significant associations for worse PROMIS anxiety (p < 0.001), depression (p < 0.001), and fatigue (p < 0.001) scores alongside poorer executive function (p < 0.001) within the high-risk group. The p-value threshold used for significance was p < 0.05.


Disclosures: J. Zhou: None; S. Fevrier: None; P. Moaf: None; L. Ng: None; A. Jeyanathan: None; L. Boulard: None; D. Levy: AbbVie/Abbott, 5, AstraZeneca, 5, Bristol-Myers Squibb(BMS), 5, Roche, 5; L. Hiraki: Janssen, 2, 5; A. Danguecan: None; A. Knight: Pfizer, 6.

To cite this abstract in AMA style:

Zhou J, Fevrier S, Moaf P, Ng L, Jeyanathan A, Boulard L, Levy D, Hiraki L, Danguecan A, Knight A. Adverse Childhood Experiences: Prevalence and Relationship to Disease and Mental Health Outcomes in Childhood-Onset Systemic Lupus Erythematosus (cSLE) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/adverse-childhood-experiences-prevalence-and-relationship-to-disease-and-mental-health-outcomes-in-childhood-onset-systemic-lupus-erythematosus-csle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/adverse-childhood-experiences-prevalence-and-relationship-to-disease-and-mental-health-outcomes-in-childhood-onset-systemic-lupus-erythematosus-csle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology